Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06405217
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-04-29
Brief Title:
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
Sponsor:
Nanjing First Hospital Nanjing Medical University
Organization:
Nanjing First Hospital Nanjing Medical University
Organization Data
Organization:
Nanjing First Hospital Nanjing Medical University
Class:
OTHER
Study ID:
KY20240419-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanjing First Hospital Nanjing Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Feng Wang
Responsible Party Title:
Director of nuclear medicine department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Nanjing First Hospital Nanjing Medical University
Old Name:
None
Old Organization:
None